• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis

    pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidurâ„¢ for Posterior Uveitis

  2. Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results

    Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results

  3. ICL and AkzoNobel Enter Agreements to Produce and Market Vaccuum Salt and White Potash

    ICL and AkzoNobel Enter Agreements to Produce and Market Vaccuum Salt and White Potash

  4. Complexities of Eye Care Drive Strong Moats

    We see attractive growth opportunities for the ophthalmology market.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.